Susquehanna International Group, LLP Fibrogen Inc Put Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$0.89 - $2.36 $444,021 - $1.18 Million	498,900 Added 345.74%	643,200 $572,000
Q1 2024 May 07, 2024	BUY	$0.73 - $2.73 $105,339 - $393,939	144,300 New	144,300 $339,000
Q2 2023 Aug 11, 2023	BUY	$2.49 - $20.59 $1.01 Million - $8.33 Million	404,400 Added 162.08%	653,900 $1.77 Million
Q1 2023 May 16, 2023	BUY	$15.95 - $25.18 $2.91 Million - $4.6 Million	182,700 Added 273.5%	249,500 $4.66 Million
Q4 2022 Feb 14, 2023	SELL	$13.27 - $17.73 $208,339 - $278,361	-15,700 Reduced 19.03%	66,800 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $242,820 - $310,980	-21,300 Reduced 20.52%	82,500 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $146,890 - $239,760	18,500 Added 21.69%	103,800 $1.1 Million
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $861,834 - $1.2 Million	-71,700 Reduced 45.67%	85,300 $1.03 Million
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $418,053 - $647,919	-42,100 Reduced 21.15%	157,000 $2.21 Million
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $2.11 Million - $5.53 Million	-207,700 Reduced 51.06%	199,100 $2.04 Million
Q2 2021 Aug 11, 2021	BUY	$18.57 - $35.68 $3.82 Million - $7.34 Million	205,800 Added 102.39%	406,800 $10.8 Million
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $1.48 Million - $2.66 Million	-47,700 Reduced 19.18%	201,000 $6.98 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $3.01 Million - $3.98 Million	81,200 Added 48.48%	248,700 $9.22 Million
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $1.32 Million - $1.49 Million	-32,700 Reduced 16.33%	167,500 $6.89 Million
Q2 2020 Aug 14, 2020	SELL	$32.57 - $42.83 $566,718 - $745,242	-17,400 Reduced 8.0%	200,200 $8.11 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $2.14 Million - $4.22 Million	-91,800 Reduced 29.67%	217,600 $7.56 Million
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $3,458 - $4,806	100 Added 0.03%	309,400 $13.3 Million
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $2.9 Million - $3.8 Million	78,500 Added 34.01%	309,300 $11.4 Million
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $10.4 Million - $16.4 Million	-296,200 Reduced 56.2%	230,800 $10.4 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $8.21 Million - $11.5 Million	191,600 Added 57.13%	527,000 $28.6 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $869,513 - $1.38 Million	-22,900 Reduced 6.39%	335,400 $15.5 Million
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $2.62 Million - $3.13 Million	-46,600 Reduced 11.51%	358,300 $21.8 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $3.73 Million - $5.39 Million	-83,000 Reduced 17.01%	404,900 $25.3 Million
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $2.51 Million - $3.41 Million	55,300 Added 12.78%	487,900 $22.5 Million
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $3.68 Million - $5.27 Million	-87,700 Reduced 16.86%	432,600 $20.5 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $17.4 Million - $28 Million	520,300	520,300 $28 Million

Others Institutions Holding FGEN

# of Institutions

115

Shares Held

57.5M

Call Options Held

2.14M

Put Options Held

907K

Primecap Management CO Pasadena, CA

13.7M
Shares

$5.33 Million
0.01% of portfolio
Armistice Capital, LLC New York, NY

8.94M
Shares

$3.49 Million
0.1% of portfolio
Vanguard Group Inc Valley Forge, PA

5.89M
Shares

$2.3 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.36M
Shares

$1.31 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$939,763
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $36.6M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account